Drug Information
Drug Generic Name | SITAGLIPTIN |
Drug Class | OTHER ANTIDIABETIC DRUGS |
Chapter | Endocrine System |
Indications: diabetes mellitus Cautions: discontinue if symptoms of acute pancreatitis (persistent, severe abdominal pain). Contra-indications: ketoacidosis Renal impairment: reduce dose to 50 mg once daily if eGFR 3050 ml/minute/1.73 m2; reduce dose to 25 mg once daily if eGFR less than 30 ml/minute/1.73 m2. Pregnancy: avoid—toxicity in animal studies. Breast-feeding: avoid—present in milk in animal studies. Side Effects: gastro-intestinal disturbances; peripheral oedema; upper respiratory tract infection, nasopharyngitis; pain; less commonly dry mouth, anorexia, headache, drowsiness, dizziness, hypoglycaemia, osteoarthritis; pancreatitis, rash, cutaneous vasculitis, and Stevens-Johnson syndrome. Dose: ADULT over 18 years, 100 mg once daily. Note: Dose of concomitant sulfonylurea or insulin may need to be reduced. |
|
Brand Name |
|